Incorporating diagnostic testing into economic evaluations of tumour-agnostic therapies
{{output}}
Introduction: Tumor-agnostic treatments represent paradigm shift in oncology, targeting specific genetic mutations irrespective of the tumor's anatomical origin. This personalized approach relies on companion diagnostic testing ... ...
